Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GWAS shows links between EDARADD and LRFN5 and performance in professional athletes.

BMC sports science, medicine & rehabilitation·2025
Same author

[A clinical case of reverse left ventricular remodeling in patient with pathogenic TTN mutation. Case report].

Terapevticheskii arkhiv·2024
Same author

[Correction of gut dysbiosis as a promising direction in the prevention of neuroinflammation and cognitive impairment].

Voprosy pitaniia·2024
Same author

Cognitive impairment in long-living adults: a genome-wide association study, polygenic risk score model and molecular modeling of the APOE protein.

Frontiers in aging neuroscience·2023
Same author

[Fracture healing under intramedullary insertion of wires with hydroxyapatite coating].

Vestnik Rossiiskoi akademii meditsinskikh nauk·2015
Same author

[Cardiac angiosarcoma in a pregnant women].

Kardiologiia·2012

Related Experiment Video

Updated: May 31, 2026

The In ovo CAM-assay as a Xenograft Model for Sarcoma
12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

[Cardiac angiosarcoma].

N A Kir'ianov, M V Terekhov, S A Sukhanov

    Arkhiv Patologii
    |June 24, 2011
    PubMed
    Summary

    This case study details cardiac angiosarcoma, a rare heart tumor. It covers the tumor's appearance and diagnostic methods for accurate identification.

    Area of Science:

    • Cardiovascular Pathology
    • Oncology
    • Diagnostic Pathology

    Background:

    • Cardiac angiosarcoma is an exceptionally rare and aggressive primary malignancy of the heart.
    • Early diagnosis is challenging due to nonspecific symptoms and rarity.

    Observation:

    • The paper presents a specific case of cardiac angiosarcoma.
    • Detailed gross pathological descriptions of the tumor are provided.
    • Microscopic examination reveals characteristic cellular morphology.

    Findings:

    • The study outlines key histological features for identifying cardiac angiosarcoma.
    • Immunomorphological diagnostic procedures are detailed.
    • The case highlights diagnostic criteria for this rare cardiac tumor.

    Related Experiment Videos

    Last Updated: May 31, 2026

    The In ovo CAM-assay as a Xenograft Model for Sarcoma
    12:44

    The In ovo CAM-assay as a Xenograft Model for Sarcoma

    Published on: July 17, 2013

    Implications:

    • Accurate diagnosis of cardiac angiosarcoma is crucial for appropriate patient management.
    • Understanding gross and microscopic characteristics aids in differentiating from other cardiac masses.
    • This case contributes to the literature on diagnosing rare cardiovascular tumors.